PatentGranted VerifiedLow Risk
AI-Powered Medical Imaging Diagnostics Platform
Deep learning system achieving 97.3% accuracy on early-stage cancer detection across CT, MRI, and X-ray modalities. FDA 510(k) clearance obtained. Deployed in 3 hospital pilot programs with 180k+ scans processed.
Owner
MIT Technology Licensing Office
Maturity
Commercialized
Commercial
For Sale
Filing Date
March 22, 2021
Grant Date
May 18, 2023
Expires
March 22, 2041
Jurisdictions
USEUUKCA
Technology Tags
Deep LearningComputer VisionMedical ImagingDiagnostic AI
5,210 views 203 saved 22 inquiries 89 citations
Application Number
US17/209,334
Grant Number
US11,723,445B2
Litigation Status
No litigation history
Market Comparables
Enlitic acquisition ($27M)
Aidoc Series C ($66M)
Express Interest
Deal room created
Open Deal RoomKey Metrics
Asking Price$15,000,000
Valuation Low$12,000,000
Valuation High$22,000,000
Risk Score3/10 (Low Risk)
Citations89
Related IP
Healthcare Federated ML
$12.0M – $22.0M